The pathogenesis of scleroderma: The role of autocrine TGF-β signaling

Connective Tissue

Volumn 36, Issue 4, 2004, Pages 209-216

  Ihn, Hironobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Collagen; Extracellular matrix; Fibrosis; Signal transduction; Smad

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEINASE INHIBITOR; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

APOPTOSIS; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; MESENCHYME CELL; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; SCLERODERMA; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS;

EID: 11144257684     PISSN: 0916572X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. LeRoy, E.G. (1992) Systemic sclerosis (scleroderma). In: Wyngaarden, J.B., Smith, L.H., and Bennett, J.C. (eds) Cecil Text Book of Medicine. 19th ed. WB Saunders, Philadelphia, pp. 1530-1535
2. Korn, J.H. (1991) Immunological aspects of scleroderma. Curr. Opin. Rheumatol. 3, 947-952
3. LeRoy, E.G. (1992) A brief overview of the pathogenesis of scleroderma (systemic sclerosis). Ann. Rheum. Dis. 51, 286-288
4. Ihn, H. (2002) Pathogenesis of fibrosis: role of TGF-β and CTGF. Curr. Opin. Rheumatol. 14, 681-685
5. Ihn, H. (2002) The role of TGF-β signaling in the pathogenesis of fibrosis in scleroderma. Arch, Immunol. Ther. Exp. 50, 325-331
6. 2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J. Clin. Invest. 86, 917-922
7. Jelaska, A., Arakawa, M., Broketa, G., and Korn, J.H. (1996) Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts: increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis. Rheum. 39, 1338-1346
8. LeRoy, E.G. (1974) Increased collagen synthesis by scleroderma skin fibroblasts in vivo. J. Clin. Invest. 54, 880-889
9. Peltonen, J., Kahari, L., Uitto, J., and Jimenez, S.A. (1990) Increased expression of type VI collagen genes in systemic sclerosis. Arthritis Rheum. 33, 1829-1835
10. Xu, W., LeRoy, E.G., and Smith, E.A. (1991) Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-β. J. Rheumatol. 18, 241-246
11. Ludnica, L., Varga, J., Christiano, A.M., Iozzo, R.V., Jimenez, S.A., and Uitto, J. (1994) Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-β. J. Clin. Invest. 93, 1709-1715
12. Falanga, V., Tiegs, S.L., Alstadt, S.P., Roberts, A.B., and Sporn, M.B. (1987) Transforming growth factor β: selective increase in glycosaminoglycan synthesis by cultures of fibroblasts from patients with progressive systemic sclerosis. J. Invest. Dermatol. 89, 100-104
13. Ihn, H. and Tamaki, K. (2000) Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: association with increased expression of type 1 collagen gene. Arthritis Rheum. 43, 2240-2247
14. Ihn, H., Yamane, K., Kubo, M., and Tamaki, K: (2001) Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor β receptors. Arthritis Rheum. 44, 474-480
15. Mimura, Y., Ihn, H., Jinnin, M., Asano, Y., Yamane, K., and Tamaki, K. (2004) Epidermal growth factor induces fibronectin expression in human dermal fibroblasts via protein kinase C δ signaling pathway. J. Invest. Dermatol. 122, 1390-1398
16. Kirk, T.Z., Mark, M.E., Chua, C.C., Chau, B.H., and Mayers, M.D. (1995) Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloprotainase (TIMP-1) with two forms of TIMP-1. J. Biol. Chem. 270, 3423-3428
17. Ihn, H., Sato, S., Fujimoto, M., Kikuchi, K., Kadono, T., Tamaki, T., Tamaki, K., and Takehara, K. (1997) Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: Enhancement by inflammatory cytokines. Br. J. Rheumatol. 36, 1270-1275
18. Duncan, M.A., Hasan, A., and Berman, B. (1995) Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. J. Invest. Dermatol. 104, 128-133
19. Lee, K.S., Ro, Y.J., Ryoo, Y.W., Kwon, H.J., and Song, J.Y. (1996) Regulation of interleukin-4 on collagen gene expression by systemic sclerosis fibroblasts in culture. J. Dermatol. Sci. 12, 110-117
20. Massague, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell Biol. 6, 597-641
21. LeRoy, E.G., Smith, E.A., Kahaleh, M.B., Trojanowska, M., and Silver, R.M. (1989) A strategy for determining the pathogenesis of systemic sclerosis: is transforming growth factor β the answer? Arthritis Rheum. 32, 817-825
22. Clark, R. A. (1985) Cutaneous tissue repair: Basic biological considerations. J. Am. Acad. Dermatol. 13, 701-725
23. Border, W.A. and Ruoslahti, E. (1992) Transforming growth factor-β: the dark side of tissue repair. J. Clin. Invest. 90, 1-7
24. Gospodarovvicz, D. and Moran, J.S. (1975) Mitogenic effect of fibroblast growth factor on early passage cultures of human murine fibroblasts. J. Cell Biol. 66, 451-457
25. Cohen, S. and Carpenter, G. (1975) Human epidermal growth factor: isolation and chemical and biological properties. Proc. Natl. Acad. Sci. USA 72, 1317-1321
26. Rutherford, R.B. and Ross, R. (1976) Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate. J. Cell Biol. 69, 196-203
27. Beutler, B. and Cerami. A. (1986) Cathectin and tumor necrosis factor as two sides of the same biological coin. Nature 320, 584-588
28. Postlethwaite, A.E., Holness, M.A., Katai, H., and Raghow, R. (1992) Human fibroblasts synthesize elevated levels of extracellular matrix protein in response to interleukin 4. J. Clin. Invest. 90, 1479-1485
29. Duncun, M.R. and Berman, B. (1989) Differential regulation of collagen, glycosaminoglycan, fibronectin and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-α and β and tumor necrosis factor-α and β. J. Invest. Dermatol. 92, 699-706
30. Duncun, M.R. and Berman, B. (1991) Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. J. Invest. Dermatol. 97, 686-692
31. Ihn, H. and Tamaki, K. (2000) Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J. Immunol. 165, 2149-2155
32. Attisano, L. and Wrana, J.L. (1996) Signal transduction by members of the transforming growth factor-β super-family. Cytokine Growth Factor Rev. 7, 327-339
33. Massague, J, (1998) TGF-β signal transduction. Ann. Rev. Biochem. 67, 753-791
34. Nunes, I., Gleizes, P.E., Metz, C.N., and Rifkin, D.B. (1997) Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β. J. Cell Biol. 136, 1151-1163
35. Oi, M., Yamamoto, M., and Nishioka, K. (2004) Increased expression of TGF-β1 in the sclerotic skin in bleomycin-'susceptible' mouse strains. J. Med. Dent. Sci. 51, 7-17
36. Needleman, B.W., Choi, J., Burrows-Menzu, A., and Fontana, J. A. (1990) Secretion and binding of transforming growth factor β by scleroderma and normal dermal fibroblasts. Arthritis Rheum. 33, 650-653
37. Wrana, J.L., Attisano, L., Weisser, R., Ventura, F., and Massague, J. (1994) Mechanism of activation of the TGF-β receptor. Nature 370, 341-347
38. Saitoh, M., Nishitoh, H., Amagasa, T., Miyazono, K., Takagi, M., and Ichijo, H. (1996) Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor β. J. Biol. Chem. 271, 2769-2775
39. Kawakami, T., Ihn, H., Xu, W., Smith, E., LeRoy, C., and Trojanowska, M. (1998) Increased expression of TGF-β receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-β signaling to scleroderma phenotype. J. Invest. Dermatol. 110, 47-51
40. Kubo, M., Ihn, H., Yamane, K., and Tamaki, K. (2001) Up-regulated expression of transforming growth factor β receptors in dermal fibroblasts in skin sections from patients with localized scleroderma. Arthritis Rheum. 44, 731-734
41. Roulot, D., Sevcsik, A.M., Coste, T., Strosberg, A.D., and Marullo, S. (1999) Role of transforming growth factor β type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology 29, 1730-1738.
42. Kubo, M., ihn, H., Yamane, K., and Tamaki, K. (2002) Upregulated expression of transforming growth factor-β receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis. J. Rheumatol. 29, 2558-2564
43. Yamane, K., Ihn, H., Kubo, M., and Tamaki, K. (2002) Increased transcriptional activities of transforming growth factor β receptors in scleroderma fibroblasts. Arthritis Rheum. 46, 2421-2428
44. Yamane, K., Ihn, H., and Tamaki, K. (2003) Epidermal growth factor up-regulates expression of transforming growth factor β receptor type II in human dermal fibroblasts by phosphoinositide 3-kinase/ Akt signaling pathway: resistance to epidermal growth factor stimulation in scleroderma fibroblasts. Arthritis Rheum. 48, 1652-1666
45. Yamane, K., Ihn, H., Asano, Y., Jinnin, M., and Tamaki, K. (2003) Antagonistic effects of TNF-α on TGF-β signaling through down-regulation of TGF-β receptor type II in human dermal fibroblasts. J. Immunol. 171, 3855-3862
46. Bloom, B.B., Humphries, D.E., Kuang, P.P., Fine, A., and Goldstein, R.H. (1996) Structure and expression of the promoter for the R4/ALK5 human type 1 transforming growth factor-β receptor: regulation by TGF-β. Biochim. Biophys. Acta. 1312, 243-248
47. Czuwara-Ladykowska, J., Gore, E.A., Shegogue, D.A., Smith, E.A., and Trojanowska, M. (2001) Differential regulation of transforming growth factor-β receptors type I and type II by platelet-derived growth factor in human dermal fibroblasts. Br. J. Dermatol. 145, 569-575
48. Leask, A., Abraham, D.J., Finlay, D.R., Holmes, A., Pennington, D., Shi-Wen, X., Chen, Y., Venstrom, K., Dou, X., Ponticos, M., Black, C., Bernabeu, C., Jackman, J.K., Findell, P.R., and Connolly, M.K. (2002) Dys-regulation of transforming growth factor-β signaling in scleroderma: overexpression of endoglin in cutaneous scleroderma fibroblasts. Arthritis Rheum. 46, 1857-1865
49. Pannu, J., Gore-Hyer, E., Yamanaka, M., Smith, E.A., Rubinchik, S., Dong, J.Y., Jablonska, M, Blaszczyk, M., and Trojanowska, M. (2004) An increased transforming growth factor β receptor type I: type 11 ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor β receptor type II in scleroderma. Arthritis Rheum. 50, 1566-1577
50. Qi, Z., Atsuchi, N., Ooshima, A., Takeshita, A., and Ueno, H. (1999) Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc. Natl. Acad. Sci. USA 96, 2345-2349
51. Trojanowska, M., Smith, E., Dong, J.Y., and Gore, E. (1999) Overexpression of a kinase-deficient TGFβ receptor II via an adenoviral vector potently inhibits extracellular matrix production in scleroderma and normal dermal fibroblasts. Arthritis Rheum. 42, S203
52. Massague, J. and Chen, Y.G. (2000) Controlling TGF-β signaling. Genes Dev. 14, 627-644
53. Shi, Y., Hata, A., Lo, R.S., Massague, J., and Pavletich, N.P. (1997) A structure basis for mutational inactivation of the tumor suppressor Smad4. Nature 388, 87-93
54. Zawel, L., Dai, J.L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., and Kern, S.E. (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617
55. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M., and Miyazono, K. (1997) Smad6 inhibits signaling by the TGF-β superfamily. Nature 389, 622-626
56. Ihn, H., Ohnishi, K., Tamaki, T., LeRoy, E.G., and Trojanowska, M. (1996) Transcriptional regulation of the human α2(I) collagen gene: combined action of upstream stimulatory and inhibitory cis-acting element. J. Biol. Chem. 271, 26717-26723
57. Ihn, H., LeRoy, E.G., and Trojanowska, M. (1997) Oncostatin M stimulates transcription of the human α2(I) collagen gene via the Sp1/Sp3-binding site. J. Biol. Chem. 272, 24666-24672
58. Ihn, H. and Trojanowska, M. (1997) Sp3 is a transcriptional activator of the human α2(I) collagen gene. Nucleic Acids Res. 25, 3712-3717
59. Ihn, H. and Tamaki, K. (2000) Competition analysis of the human αr2(I) collagen promoter using synthetic oligonucleotides. J. invest. Dermatol. 114, 1011-1016
60. Ihn, H., Ihn, Y., and Trojanowska, M, (2001) Sp1 phosphorylation induced by serum stimulates the human α2(I) collagen gene. J. Invest. Dermatol. 117, 301-308
61. Inagaki, Y., Truter, S., and Ramirez, F. (1994) Transforming growth factor-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J. Biol. Chem. 269, 14828-14834
62. 1. J. Biol. Chem. 272, 19738-19745
63. Chen, S.J., Yuan, W., Mori, Y., Levenson, A., Trojanowska, M., and Varga, J. (1999) Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: Involvement of Smad3. J. Invest. Dermatol. 112, 49-57
64. Chen, S.J., Yuan, W., Lo, S., Trojanowska, M., and Varga, J. (2000) Interaction of Smad3 with proximal Smad-binding element of the human α2(I) collagen gene promoter required for transcriptional activation by TGF-β. J. Cell. Physiol. 183, 381-392
65. Mori, Y., Chen, S.J., and Varga, J. (2000) Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-β, Exp. Cell Res. 258, 374-383
66. 1 stimulation of α2(I) collagen (COL1 A2) transcription. J. Biol. Chem. 275, 39237-39245
67. 1-induced α2(I) collagen expression in human glomerular mesangial cells. J. Biol. Chem. 276, 6983-6992
68. Inagaki, Y., Nemoto, T., Nakao, A., ten Dijke, P., Kobayashi, K., Takehara, K., and Greenwel, P. (2001) Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2(I) collagen gene transcription. J. Biol. Chem. 276, 16573-16579
69. Ghosh, A.K., Yuan, W., Mori, Y., and Varga, J. (2000) Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 19, 3546-3555
70. Ghosh, A.K., Yuan, W., Mori, Y., Chen, S.J., and Varga, J. (2001) Antagonistic regulation of type I collagen gene expression by interferon-γ and transforming growth factor-β. Integration at the level of p300/CBP transcriptional coactivators. J. Biol. Chem. 276, 11041-11048
71. Czuwara-Ladykowska, J., Sementchenko, V.I., Watson, F.K., and Trojanowska, M. (2002) Ets1 is an effector of the TGF-β signaling pathway and an antagonist of the profibrotic effects of TGF-β. J. Biol. Chem. 277, 20399-20408
72. Jinnin, M., Ihn, H., Asano, Y., Yamane, K., Trojanowska, M., and Tamaki, K. (2004) Tenascin-C upregulation by transforming growth factor-β in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Oncogene 23, 1656-1667
73. Shirasaki, F., Makhluf, H.A., LeRoy, E.C., Watson, D.K., and Trojanowska, M. (1999) Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 18, 7754-7764
74. Czuwara-Ladykowska, J., Shirasaki, F., Jackers, P., Watson, D.K., and Trojanowska, M. (2001) Fli-1 inhibits collagen type I production in human dermal fibroblasts via an Sp-dependent manner. J. Biol. Chem. 15, 20839-20848
75. Trojanowska, M. (2000) Ets factors and regulation of the extracellular matrix. Oncogene 18, 6464-6471
76. Yuan, W. and Varga, J. (2001) Transforming growth factor-β repression of matrix metalloproteinase 1 in dermal fibroblasts involves Smad3. J. Biol. Chem. 276, 38502-38510
77. Flanders, K.C, Sullivan, C.D., Fujii, M., Sowers, A, Anzano, M.A., Arabshahi, A., Major, C., Deng, C., Russo, A., Mitchell, J.B., and Roberts, A.B. (2002) Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am. J. Pathol. 160, 1057-1068
78. Zhao, J., Shi, W., Wang, Y.L., Chen, H., Bringas, P., Jr., Datto, M.B., Frederick, J.P., Wang, X.F., and Warburton, D. (2002) Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 282, 585-593
79. Lee, D.K., Park, S.H., Yi, Y., Choi, S.G., Lee, C., Parks, W.T., Cho, H., de Caestecker, M.P., Shual, Y., Roberts, A.B., and Kim, S.J. (2001) The hepatitis B virus encoded oncoprotein pX amplifies TGF-β family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev. 15, 455-466
80. Schnabl, B., Kweon, Y.O, Frederick, J.P., Wang, X.F., Rippe, R.A., and Brenner, D.A. (2001) The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34, 89-100
81. Inagaki, Y., Mamura, M., Kanamaru, Y., Greenwel, P., Nemoto, T., Takehara, K., ten Dijke, P., and Nakao, A. (2001) Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic satellate cells. J. Cell. Physiol. 187, 117-123
82. Takahashi, Y., Matsuzaki, K., Date, M., Yoshida, K., Furukavva, F., Sugano, Y., Matsushita, M., Himeno, Y., Inagaki, Y., and Inoue, K. (2002) Differential regulation of TGF-β signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35, 49-61
83. Terada, Y., Hanada, S., Nakao, A., Kuwahara, M., Sasaki, S., and Marumo, F. (2002) Gene transfer of Smad7 using electroporation of adenovirus prevents renal fibrosis in post-obstructed kidney. Kidney Int. 61, 94-98
84. Holmes, A., Abraham, D.J., Sa, S., Shiwen, X., Black, C. M., and Leask, A. (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J. Biol. Chem. 276, 10594-10601
85. Mori, Y., Chen, S.J., and Varga, J. (2003) Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts. Arthritis Rheum. 48, 1964-1978
86. Asano, Y., Ihn, H., Yamane, K., Jinnin, M., Mimura, Y., and Tamaki, K. (2004) Phosphatidylinositol 3-kinase is involved in α2(I) collagen gene expression in normal and scleroderma fibroblasts. J. Immunol. 172, 7123-7135
87. Dong, C., Zhu, S., Wang, T., Yoon, W., Alvarez, R.J., ten Dijke, P., White, B., Wigley, P.M., and Goldschmidt-Clemont, P.J. (2002) Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc. Natl. Acad. Sci. USA 99, 3908-3913
88. Asano, Y., Ihn, H., Yamane, K., Kubo, M., and Tamaki, K. (2004) Impaired Smad7-Smurf-mediated negative regulation of TGF-β signaling in scleroderma fibroblasts. J. Clin. Invest. 113, 253-264
89. Seger, R. and Krebs, E.G. (1995) The MAPK signaling cascade. FASEB J. 9, 726-735
90. Ihn, H., Yamane, K., Asano, Y., Kubo, M., and Tamaki, K. (2002) 1L-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase-dependent pathway. J. Immunol. 168, 1895-1902
91. Sato, M., Shegogue, D., Gore, E.A., Smith, E.A., McDermott, P.J., and Trojanowska, M. (2002) Role of p38 MAPK in transforming growth factor β stimulation of collagen production by scleroderma and healthy dermal fibroblasts. J. Invest. Dermatol. 118, 704-711
92. Hocevar, B.A., Brown, T.L., and Howe, P.H. (1999) TGF-β induces fibronectin synthesis through a c-Jun N-termial kinase-dependent Smad4-independent pathway. EMBO J. 18, 1345-1356
93. Reunanen, N., Foschi, M., Han, J., and Hahari, V.M. (2000) Activation of extracellular signal-regulated kinase 1/2 inhibits type I collagen expression by human skin fibroblasts. J. Biol. Chem. 275, 34634-34639
94. Cantley, L.C. (2002) The phosphoinositide 3-kinase pathway. Science 296, 1655-1657
95. Toker, A. (2000) Protein kinases as mediators of phosphoinositide 3-kinase signaling. Mol. Pharmacol. 57, 652-658
96. Bakin, A.V., Tomlinson, A.K., Bhowmick, N.A., Moses, H.L., and Arteaga, CL. (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275, 36803-36810
97. 1. J. Biol. Chem. 279, 2632-2639
98. Tezuka, T., Chiang, T.A., Davison, A.F., Attisano, L., and Wrana, J.L. (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGF-β receptor. Cell 95, 779-791
99. Itoh, F., Divecha, N., Brocks, L., Oomen, L., Janssen, H., Calafat, J., Itoh, S., and ten Dijke, P. (2002) The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-β/Smad signaling. Genes Cells 7, 321-331
100. Shegogou, D. and Trojanowska, M. (2004) Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway. J. Biol. Chem. 279, 23166-23175
101. Bradham, D.M., Igarashi, A., Potter, R.L., and Grotendorst, G.R. (1991) Connective tissue growth factor: a cystein-rich mitogen secreted by human vascular endothelial cells is related to the SRC induced immediate early gene product CEF-10. J. Cell Biol. 114, 1285-1294
102. Igarashi, A., Okochi, H., Bradham, D.M., and Grotendorst, G.R. (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol. Biol. Cell 4, 637-645
103. Shinozaki, M., Kawara, S., Hayashi, N., Kakinuma, T., Igarashi, A., and Takehara, K. (1997) Induction of subcutaneous tissue fibrosis in newborn mice by transforming growth factor β: simultaneous application with basic fibroblast growth factor causes persistant fibrosis. Biochem. Biophys. Res. Commun. 240, 292-297
104. Mori, T., Kawara, S., Shinozaki, M., Hayashi, N., Kakinuma, T., Igarashi, A., Takigawa, M., Nakanishi, T., and Takehara, K. (1999) Role and interaction of connective tissue growth factor with transforming growth factor β in persistant fibrosis: a mouse fibrosis model. J. Cell. Physiol. 181, 153-159
105. Igarashi, A., Nashiro, K., Kikuchi, K., Sato, S., Ihn, H., Grotendorst, G.R., and Takehara, K. (1995) Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J. Invest. Dermatol. 105, 280-284
106. Igarashi, A., Nashiro, K., Kikuchi, K., Sato, S., Ihn, H., Fujimoto, M., Grotendorst, G.R., and Takehara, K. (1996) Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J. Invest. Dermatol. 106, 723-733
107. Frazer, K., Williams, S.K.D., Klapper, H., and Grotendorst, G.R. (1996) Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J. Invest. Dermatol. 107, 404-411
108. Paradis, V., Dargere, D., Vidaud, M., De Gouville, A.C., Huet, S., Martinez, V., Gauthier, J.M., Sobesky, R., Ratziu, V., and Bedossa, P. (1999) Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30, 968-976
109. Ziesche, R., Hofbauer, E., Wittmann, K., Petkov, V., and Block, L.H. (1999) A preliminary study of long-term treatment with interferon γ-1b and low-dose predonisolone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 341, 1264-1269
110. Abou-Shady, M., Freiss, H., Zimmermann, A., di Mola, F.F., Guo, X.Z., Baer, H.U., and Buchler, M.W. (2000) Connective tissue growth factor in human liver cirrhosis. Liver 20, 296-304
111. Chen, M.M., Lam, A., Abraham, J.A., Schreiner, G.F., and Joly, A.H. (2000) CTGF expression is induced by TGF-β in cardiac myocytes: a potential role in heart fibrosis. J. Mol. Cell. Cardiol. 32, 1805-1819
112. Stratton, R., Shiwen, X., Martini, G., Holmes, A., Leask, A., Haberberger, T., Martin, G.R., Black, C.M., and Abraham, D. (2001) Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J. Clin. Invest. 108, 241-250
113. Takehara, K. (2003) Hypothesis: pathogenesis of systemic sclerosis. J. Rheumatol. 30, 755-759
114. Gore-Hyer, E., Pannu, J., Smith, E.A., Grotendorst, G., and Trojanowska, M. (2003) Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts. Arthritis Rheum. 48, 798-806
115. Takeda, K., Hatamochi, A., Ueki, H., Nakata, M., and Oishi, Y. (1994) Decreased collagenase expression in cultured systemic sclerosis fibroblasts, J. Invest. Dermatol. 103, 359-363
116. Sappino, A.P., Masouye, I., Saurai, J.H., and Gabbiani, G. (1990) Smooth muscle differentiation in scleroderma fibroblastic cells. Am. J. Pathol. 137, 585-591
117. 5 on scleroderma dibroblasts. Am. J. Pathol. 164, 1275-1292